Spinal stimulation study aims to rewire movement after injury

NCT ID NCT05163639

Recruiting now Knowledge-focused Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study tests whether pairing brain stimulation with spinal cord stimulation can strengthen the signals that control hand muscles. Researchers will study healthy volunteers, people with spinal cord injury, and those with cervical myelopathy. The goal is to understand how this technique works and whether it could one day help restore movement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-invasive brain and spinal cord stimulation
What this could lead to: If successful, this could point toward a non-invasive way to improve arm and hand function after spinal cord injury.
What could go wrong: This is a very early, small study focused on understanding how the stimulation works, not yet testing a treatment. It may not lead to any direct benefit for participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL MYELOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

quadriplegia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL MYELOPATHY CERVICAL SPINAL CORD INJURY TETRAPLEGIA/TETRAPARESIS

Contacts and locations

Locations

Bronx Veterans Medical Research Foundation, Inc
RECRUITING

New York, New York, 10029, United States
Columbia University Irving Medical Center
RECRUITING

New York, New York, 10032, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.